Please login to order a test.
Monitor 14-Drug Class Profile (LabCorp MedWatch®)
- Immunoassay 14
Amphetamine; barbiturates; benzodiazepines; buprenorphine; cocaine (and metabolite); creatinine; fentanyl; meperidine; methadone; opiate; oxycodone/oxymorphone; pH; phencyclidine (PCP); propoxyphene; specific gravity; tetrahydrocannabinol (THC); tramadol. Note: Contains expanded benzodiazepine confirmation upon reflex of positive screen. Positive expanded benzodiazepine screen includes alpha-hydroxy-alprazolam, alpha-hydroxy-midazolam, alpha-hydroxy-triazolam, 7-aminoclonazepam, hydroxy-ethyl-flurazepam, lorazepam, nordiazepam, oxazepam, and temazepam. Opiate confirmation of positive screen includes hydrocodone, hydromorphone, codeine, and morphine.
Detect and confirm presence of prescribed and illicit drugs
Initial testing by immunoassay (IA); confirmation of positive by mass spectrometry (MS)
Maintain specimen at room temperature. If arrival at laboratory extends beyond seven days, refrigerate.
This profile is designed for pain management. It is not intended for workplace testing and does not comply with state regulatory workplace testing programs.